Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 18
2004 20
2005 31
2006 30
2007 40
2008 55
2009 45
2010 29
2011 29
2012 30
2013 32
2014 27
2015 26
2016 28
2017 33
2018 24
2019 19
2020 32
2021 48
2022 17
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

556 results

Results by year

Filters applied: . Clear all
Page 1
Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer.
Dos Santos GA, Viana NI, Pimenta R, de Camargo JA, Guimaraes VR, Romão P, Candido P, Dos Santos VG, Ghazarian V, Reis ST, Leite KRM, Srougi M. Dos Santos GA, et al. Among authors: srougi m. Cancer Genet. 2024 Mar 16;284-285:20-29. doi: 10.1016/j.cancergen.2024.03.006. Online ahead of print. Cancer Genet. 2024. PMID: 38503134
The landscape of biomedical research funding in Brazil: a current overview.
Gomes CM, Marchini G, de Bessa J Júnior, Carvalhal G, Caldeira MPR, Saldiva PH, Krieger JE, Agena F, Reis S, Paschoal C, Froes M, Srougi M, Nahas WC, Favorito LA. Gomes CM, et al. Among authors: srougi m. Int Braz J Urol. 2024 Mar-Apr;50(2):209-222. doi: 10.1590/S1677-5538.IBJU.2024.9905. Int Braz J Urol. 2024. PMID: 38386791 Free PMC article. Review.
Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression.
Pimenta R, Malulf FC, Romão P, Caetano GVB, da Silva KS, Ghazarian V, Dos Santos GA, Guimarães V, Silva IA, de Camargo JA, Recuero S, Melão BVLA, Antunes AA, Srougi M, Nahas W, Leite KRM, Reis ST. Pimenta R, et al. Among authors: srougi m. J Cancer Res Clin Oncol. 2024 Feb 2;150(2):70. doi: 10.1007/s00432-023-05598-x. J Cancer Res Clin Oncol. 2024. PMID: 38305916 Free PMC article.
Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer.
Pimenta R, Mioshi CM, Gonçalves GL, Candido P, Camargo JA, Guimarães VR, Chiovatto C, Ghazarian V, Romão P, da Silva KS, Dos Santos GA, Silva IA, Srougi M, Nahas WC, Leite KR, Viana NI, Reis ST. Pimenta R, et al. Among authors: srougi m. Int J Mol Sci. 2023 Jun 1;24(11):9633. doi: 10.3390/ijms24119633. Int J Mol Sci. 2023. PMID: 37298588 Free PMC article.
Cholesterol Triggers Nuclear Co-Association of Androgen Receptor, p160 Steroid Coactivators, and p300/CBP-Associated Factor Leading to Androgenic Axis Transactivation in Castration-Resistant Prostate Cancer.
Pimenta R, Camargo JA, Candido P, Ghazarian V, Gonçalves GL, Guimarães VR, Romão P, Chiovatto C, Mioshi CM, Dos Santos GA, Silva IA, Birbrair A, Srougi M, Nahas WC, Leite KR, Viana NI, Reis ST. Pimenta R, et al. Among authors: srougi m. Cell Physiol Biochem. 2022 Dec 2;56(S4):1-15. doi: 10.33594/000000592. Cell Physiol Biochem. 2022. PMID: 36458578 Free article.
Can we use Ki67 expression to predict prostate cancer aggressiveness?
Maia R, Santos GAD, Reis S, Viana NI, Pimenta R, Guimarães VR, Recuero S, Romão P, Leite KRM, Srougi M, Passerotti CC. Maia R, et al. Among authors: srougi m. Rev Col Bras Cir. 2022 Jul 1;49:e20223200. doi: 10.1590/0100-6991e-20223200-en. eCollection 2022. Rev Col Bras Cir. 2022. PMID: 35792806 Free PMC article.
Corrigendum to <MicroRNA expression profiles in the progression of prostate cancer - From high-grade prostate intraepithelial neoplasia to metastasis> [Urologic Oncology: Seminars and Original Investigations 31/6 (August, 2013) 796-801].
Leite KRM, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Camara-Lopes LH, Srougi M. Leite KRM, et al. Among authors: srougi m. Urol Oncol. 2022 Aug;40(8):388. doi: 10.1016/j.urolonc.2022.05.005. Epub 2022 Jun 1. Urol Oncol. 2022. PMID: 35659484 No abstract available.
Reply by Authors.
Guglielmetti GB, Dos Anjos GC, Sawczyn G, Rodrigues G, Cardili L, Cordeiro MD, Neves LCO, Pontes Junior J, Fazoli A, Coelho RF, Srougi M, Nahas WC. Guglielmetti GB, et al. Among authors: srougi m. J Urol. 2022 Aug;208(2):267. doi: 10.1097/JU.0000000000002695.03. Epub 2022 May 24. J Urol. 2022. PMID: 35607900 No abstract available.
556 results